This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • HIV infection
  • /
  • Two-drug regimens with dolutegravir plus rilpiviri...

Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naïve, virologically-suppressed patients: Latest evidence from the literature on their efficacy and safety

Read time: 1 mins
Published:29th Feb 2020
Author: Cento V, Perno CF.
Availability: Free full text
Ref.:J Glob Antimicrob Resist. 2020 Mar;20:228-237.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest